Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in stroke therapy

A Goldszmidt1, R J Wityk

  • 1Department of Medicine, Sinai Hospital of Baltimore, Johns Hopkins University School of Medicine, Maryland, USA.

Current Opinion in Neurology
|March 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vertebrobasilar dolichoectasia associated with Marfan syndrome.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2013
Same author

Crossed cerebellar diaschisis in acute stroke detected by dynamic susceptibility contrast MR perfusion imaging.

AJNR. American journal of neuroradiology·2009
Same author

Olfactory and taste dysfunction after bilateral middle cerebral artery stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2007
Same author

Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke.

Neuroradiology·2003
Same author

A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke.

Cerebrovascular diseases (Basel, Switzerland)·2003
Same author

Meningioma presenting as stroke: report of two cases and estimation of incidence.

Journal of neurology, neurosurgery, and psychiatry·2002
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Recent stroke therapy advances include new drugs and trials for acute treatment and secondary prevention. The National Institutes of Neurologic Disease and Stroke tissue plasminogen activator trial significantly impacts current stroke patient management.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Stroke therapy has seen diverse advancements in the last two years.
  • Acute stroke management and secondary prevention are key research areas.

Purpose of the Study:

  • To review recent clinical trials and therapeutic advances in stroke.
  • To highlight the impact of new findings on stroke patient care and management.

Main Methods:

  • Review of recent clinical trials.
  • Analysis of therapeutic agents including thrombolytics, anticoagulants, antiplatelet drugs, and neuroprotective agents.
  • Examination of trials involving HMG-CoA reductase inhibitors.

Main Results:

  • Positive results from the National Institutes of Neurologic Disease and Stroke tissue plasminogen activator trial have spurred interest and changes in acute stroke therapy.

Related Experiment Videos

  • New antiplatelet drugs and trials with HMG-CoA reductase inhibitors show promise for secondary stroke prevention.

    • Conclusions:

    • Significant progress has been made in both acute stroke treatment and secondary prevention strategies.
    • The findings indicate a shift towards more effective and varied therapeutic options for stroke patients.